Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - amoxicillin trihydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - amoxicillin trihydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - amoxicillin trihydrate, quantity: 28.77 mg/ml (equivalent: amoxicillin, qty 25 mg/ml) - oral liquid, powder for - excipient ingredients: silicon dioxide; sodium citrate; purified talc; aspartame; sodium benzoate; citric acid; guar gum; flavour - treatment of the following infections due to susceptible strains of sensitive organisms: note: therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. amoxycillin alone or in combination with another antibiotic, may be used in an emergency where the causative organism has not been identified. respiratory tract infections (acute and chronic) including acute otitis media (aom): h. influenzae; streptococcus; s. pneumoniae; staphylococcus, nonpenicillinase producing; e. coli (see microbiology). urogenital infections (complicated and uncomplicated, acute and chronic): e. coli (see microbiology), p. mirabilis and strep. faecalis. gonorrhoea: n. gonorrhoeae (nonpenicillinase producing). skin and skin structure infections: staphlococcus, nonpenicillinase producing; streptococcus, e. coli (see microbiology). prophlaxis of endocarditis: amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis. infections caused by pathogens with established penicillin g susceptibility should preferentially be treated with penicillin g.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - amoxicillin trihydrate, quantity: 57.4 mg/ml (equivalent: amoxicillin, qty 50 mg/ml) - oral liquid, powder for - excipient ingredients: silicon dioxide; sodium citrate; purified talc; aspartame; sodium benzoate; citric acid; guar gum; flavour - treatment of the following infections due to susceptible strains of sensitive organisms: note: therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. amoxycillin alone or in combination with another antibiotic, may be used in an emergency where the causative organism has not been identified. respiratory tract infections (acute and chronic) including acute otitis media (aom): h. influenzae; streptococcus; s. pneumoniae; staphylococcus, nonpenicillinase producing; e. coli (see microbiology). urogenital infections (complicated and uncomplicated, acute and chronic): e. coli (see microbiology), p. mirabilis and strep. faecalis. gonorrhoea: n. gonorrhoeae (nonpenicillinase producing). skin and skin structure infections: staphlococcus, nonpenicillinase producing; streptococcus, e. coli (see microbiology). prophlaxis of endocarditis: amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis. infections caused by pathogens with established penicillin g susceptibility should preferentially be treated with penicillin g.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - amoxycillin as amoxycillin trihydrate; clavulanic acid as potassium clavulanate - parenteral liquid/solution/suspension - amoxycillin as amoxycillin trihydrate antibiotic active 140.0 mg/ml; clavulanic acid as potassium clavulanate antibiotic active 35.0 mg/ml - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - actinobacillus lignieresii | actinomyces bovis | bacillus anthracis | bacteroides spp. | bordetella bronchiseptica | campylobacter spp. | clostridium spp. | corynebacteria | escherichia coli (e. coli) | fusobacterium necrophorum | haemophilus spp. | klebsiella spp. | moraxella spp. | pasteurella spp. | peptostreptococcus spp. | proteus spp. | salmonella | staphylococci | streptococci | anaerobic bacteria | anthrax | canine cough syndrome | clostridium botulinum | clostridium chauvoei | clostridium fallax | clostridium feseri | clostridium hemolyticum | clostridium novyi | clostridium perfringens types | clostridium septicum | clostridium sordelli | clostridium sporogenes | clostridium tetani | haemophilus agni | haemophilus bovis | haemophilus parainfluenzae | haemophilus parasuis | haemophilus pleuropneumoniae | haemophilus somnus | haemophilus suis | including b-lactamase producin | infectious tracheobronchitis | pasterellosis | pasteurellosis | salmonellosis

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - amoxycillin as amoxycillin trihydrate; clavulanic acid - oral tablet - amoxycillin as amoxycillin trihydrate antibiotic active 400.0 mg/tb; clavulanic acid antibiotic active 100.0 mg/tb - antibiotic & related - calf | dog | beef calf | bitch | bovine | calf - poddy | calf - preweaning | calf - sucker | castrate | dairy calf | neonatal ca - bordetella bronchiseptica | corynebacterium spp. | escherichia coli (e. coli) | klebsiella spp. | pasteurella spp. | proteus mirabilis | salmonella | staphylococcus spp. | streptococcus spp. | bacterial canker | canine cough syndrome | including b-lactamase producin | infectious tracheobronchitis | pasterellosis | pasteurellosis | salmonellosis | staphylococcosis

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - amoxycillin as amoxycillin trihydrate; clavulanic acid as potassium clavulanate - parenteral liquid/solution/suspension - amoxycillin as amoxycillin trihydrate antibiotic active 140.0 mg/ml; clavulanic acid as potassium clavulanate antibiotic active 35.0 mg/ml - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - abscess | anal sacculitis | bacterial infection | bronchitis | campylobacter spp. | cystitis | escherichia coli (e. coli) | gingivitis | infections of the respiratory tract | infections of the skin | infections of the urogenital tract | klebsiella spp. | metritis | nephritis | pharyngitis | pneumonia | post parturient infections | pyoderma | salmonella spp. | septicemia | soft tissue infections | staphylococcus spp. | tonsillitis | abscesses | acute respiratory infections | amoxycillin sensitive bacteria | anal sacculitis | associated with viral disease | bacterial pneumonia | bronchiseptica | bronchitis | cystitis | fungal | gingivitis | gram negative bacteria | gram negative organisms | gram negative septicaemias | gram positive bacteria | gram positive organisms | including b-lactamase producin | metritis | nephritis | pharyngitis | pneumonia | post parturient bacterial infe | post-parturient infections | primary bacterial infection | pyoderma | septicaemia | staphylococcosis | sulfadiazine sensitive bacte

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - amoxicillin trihydrate, quantity: 1148 mg (equivalent: amoxicillin, qty 1000 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; magnesium stearate; sodium starch glycollate type a; hypromellose; titanium dioxide; purified talc - amoxycillin sandoz is indicated in the treatment of acute exacerbation of chronic bronchitis. notes: therapy should be guided by bacteriologic studies including sensitivity tests and by clinical response. amoxycillin alone or in combination with another antibiotic, may be used in an emergency where the causative agent has yet to be identified. amoxycillin sandoz 1000mg tablets have not been shown to be bioequivalent to the 500mg and 250mg capsule formulations given in equivalent doses. therefore, amoxycillin sandoz 1000mg tablets and other forms of amoxycillin are not considered interchangeable. infections caused by pathogens with established penicllin g susceptibility should preferentially be treated with penicillin g.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

abbey laboratories pty ltd - amoxycillin trihydrate - parenteral liquid/solution/suspension - amoxycillin trihydrate antibiotic active 200.0 mg/ml - antibiotic & related

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

pharm tech - amoxycillin trihydrate(200mg/ml) - parenteral liquid/solution/suspension - antibiotic - cattle | pigs | sheep | beef | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | ew - antibiotics - oral, parenteral | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | avian mycoplasmas | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | hypermotility | infected wounds | infections | lactating | mastitis | protozoal infections | pyometra | salmonellosis | sinusitis | systemic bacterial infection